Experimental strategies for investigating psychostimulant drug actions and prefrontal cortical function in ADHD and related attention disorders

Anatomical Record

Volumn 294, Issue 10, 2011, Pages 1698-1712

  Agster, Kara L ^a   Clark, Brian D ^a   Gao, Wen Jun ^a   Shumsky, Jed S ^a   Wang, Huaixing X ^a   Berridge, Craig W ^b   Waterhouse, Barry D ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Attention deficit hyperactivity disorder; Behavioral pharmacology; Catecholamines; Dopamine; Methylphenidate; Norepinephrine; Psychostimulant

Indexed keywords

AMPHETAMINE; CATECHOLAMINE; DOPAMINE; METHYLPHENIDATE; NORADRENALIN; PSYCHOSTIMULANT AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; BRAIN FUNCTION; BRAIN NERVE CELL; COGNITION; DOSE RESPONSE; DRUG ACTIVITY; ELECTROPHYSIOLOGY; EXPERIMENTAL STUDY; HUMAN; LOCUS CERULEUS; NERVE CELL NETWORK; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; SUSTAINED ATTENTION; SYNAPTIC TRANSMISSION; TASK PERFORMANCE;

ADOLESCENT; ADULT; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR; BRAIN; CATECHOLAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; METHYLPHENIDATE; NEURONS; PREFRONTAL CORTEX; YOUNG ADULT;

ANIMALIA; RODENTIA;

EID: 80053009753     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21403     Document Type: Article

References (137)

1. Arnsten AF, Cai JX, Goldman-Rakic PS. 1988. The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes. J Neurosci 8: 4287-4298.
2. Arnsten AF, Goldman-Rakic PS. 1998. Noise stress impairs prefrontal cortical cognitive function in monkeys: evidence for a hyperdopaminergic mechanism. Arch Gen Psychiatry 55: 362-368.
3. Arnsten AF, Li BM. 2005. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57: 1377-1384.
4. Aston-Jones G, Cohen JD. 2005. An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci 28: 403-450.
5. Bennett BD, Huguenard JR, Prince DA. 1998. Adrenergic modulation of GABAA receptor-mediated inhibition in rat sensorimotor cortex. J Neurophysiol 79: 937-946.
6. Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B, Hamilton C, Spencer RC. 2006. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 60: 1111-1120.
7. Berridge CW, Morris MF. 2000. Amphetamine-induced activation of forebrain EEG is prevented by noradrenergic beta-receptor blockade in the halothane-anesthetized rat. Psychopharmacology (Berl) 148: 307-313.
8. Berridge CW, Waterhouse BD. 2003. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 42: 33-84.
9. Blanc G, Trovero F, Vezina P, Herve D, Godeheu AM, Glowinski J, Tassin JP. 1994. Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur J Neurosci 6: 293-298.
10. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS. 1979. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205: 929-932.
11. Bushnell MC, Goldberg ME, Robinson DL. 1981. Behavioral enhancement of visual responses in monkey cerebral cortex. I. Modulation in posterior parietal cortex related to selective visual attention. J Neurophysiol 46: 755-772.
12. Cai JX, Arnsten AF. 1997. Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. J Pharmacol Exp Ther 283: 183-189.
13. Ciombor KJ, Ennis M, Shipley MT. 1999. Norepinephrine increases rat mitral cell excitatory responses to weak olfactory nerve input via alpha-1 receptors in vitro. Neuroscience 90: 595-606.
14. Clark BD, Agster KL, Shumsky JS, Starr MA, Waterhouse BD. 2008. Neuronal activity and psychostimulant drug action in the rat medial prefrontal cortex during a sustained attention task. Program No. 161.11. 2008 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience.
15. Collins GG, Probett GA, Anson J, McLaughlin NJ. 1984. Excitatory and inhibitory effects of noradrenaline on synaptic transmission in the rat olfactory cortex slice. Brain Res 294: 211-223.
16. Creese I, Iversen SD. 1975. The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 83: 419-436.
17. Devilbiss DM, Waterhouse BD. 2000. Norepinephrine exhibits two distinct profiles of action on sensory cortical neuron responses to excitatory synaptic stimuli. Synapse 37: 273-282.
18. DiDomenico R, Nissanov J, Eaton RC. 1988. Lateralization and adaptation of a continuously variable behavior following lesions of a reticulospinal command neuron. Brain Res 473: 15-28.
19. Drouin C, Darracq L, Trovero F, Blanc G, Glowinski J, Cotecchia S, Tassin JP. 2002. Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J Neurosci 22: 2873-2884.
20. Drouin C, Page M, Waterhouse B. 2006. Methylphenidate enhances noradrenergic transmission and suppresses mid- and long-latency sensory responses in the primary somatosensory cortex of awake rats. J Neurophysiol 96: 622-632.
21. Eaton RC, DiDomenico R, Nissanov J. 1988. Flexible body dynamics of the goldfish C-start: implications for reticulospinal command mechanisms. J Neurosci 8: 2758-2768.
22. Eaton RC, DiDomenico R, Nissanov J. 1991. Role of the Mauthner cell in sensorimotor integration by the brain stem escape network. Brain Behav Evol 37: 272-285.
23. Evarts EV. 1960. Effects of sleep and waking on spontaneous and evoked discharge of single units in visual cortex. Fed Proc 19: 828-837.
24. Farah MJ, Illes J, Cook-Deegan R, Gardner H, Kandel E, King P, Parens E, Sahakian B, Wolpe PR. 2004. Neurocognitive enhancement: what can we do and what should we do? Nat Rev Neurosci 5: 421-425.
25. Florin SM, Kuczenski R, Segal DS. 1994. Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment. Brain Res 654: 53-62.
26. Foote SL, Bloom FE, Aston-Jones G. 1983. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol Rev 63: 844-914.
27. Foote SL, Freedman R, Oliver AP. 1975. Effects of putative neurotransmitters on neuronal activity in monkey auditory cortex. Brain Res 86: 229-242.
28. Franowicz JS, Kessler LE, Borja CM, Kobilka BK, Limbird LE, Arnsten AF. 2002. Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine. J Neurosci 22: 8771-8777.
29. Gao WJ. 2007. Acute clozapine suppresses synchronized pyramidal synaptic network activity by increasing inhibition in the ferret prefrontal cortex. J Neurophysiol 97: 1196-1208.
30. Gao WJ, Goldman-Rakic PS. 2003. Selective modulation of excitatory and inhibitory microcircuits by dopamine. Proc Natl Acad Sci USA 100: 2836-2841.
31. Gao WJ, Krimer LS, Goldman-Rakic PS. 2001. Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits. Proc Natl Acad Sci USA 98: 295-300.
32. Gao WJ, Wang Y, Goldman-Rakic PS. 2003. Dopamine modulation of perisomatic and peridendritic inhibition in prefrontal cortex. J Neurosci 23: 1622-1630.
33. Goldberg ME, Bushnell MC. 1981. Behavioral enhancement of visual responses in monkey cerebral cortex. II. Modulation in frontal eye fields specifically related to saccades. J Neurophysiol 46: 773-787.
34. Gonzalez-Islas C, Hablitz JJ. 2001. Dopamine inhibition of evoked IPSCs in rat prefrontal cortex. J Neurophysiol 86: 2911-2918.
35. Gonzalez-Islas C, Hablitz JJ. 2003. Dopamine enhances EPSCs in layer II-III pyramidal neurons in rat prefrontal cortex. J Neurosci 23: 867-875.
36. Granon S, Passetti F, Thomas KL, Dalley JW, Everitt BJ, Robbins TW. 2000. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 20: 1208-1215.
37. Greely H, Sahakian B, Harris J, Kessler RC, Gazzaniga M, Campbell P, Farah MJ. 2008. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 456: 702-705.
38. Greenhill LL. 2001. Clinical effects of stimulant medication in ADHD. In: Solanto MV, Arnsten AFT, Castellanos FX, editors. Psychostimulant drugs and ADHD: basic and clinical neuroscience. New York: Oxford University Press. p 31-71.
39. Haber S, Barchas PR, Barchas JD. 1981. A primate analogue of amphetamine-induced behaviors in humans. Biol Psychiatry 16: 181-196.
40. Hibbert K. 2007. Ways to make you think better. The Guardian., Nov 8, 2007.
41. Hyvarinen J, Poranen A, Jokinen Y. 1980. Influence of attentive behavior on neuronal responses to vibration in primary somatosensory cortex of the monkey. J Neurophysiol 43: 870-882.
42. Jakala P, Sirvio J, Riekkinen M, Koivisto E, Kejonen K, Vanhanen M, Riekkinen P, Jr. 1999. Guanfacine and clonidine, alpha 2-agonists, improve paired associates learning, but not delayed matching to sample, in humans. Neuropsychopharmacology 20: 119-130.
43. Kahneman D. 1973. Attention and effort. Englewood Cliffs, NJ: Prentice-Hall.
44. Kasamatsu T, Heggelund P. 1982. Single cell responses in cat visual cortex to visual stimulation during iontophoresis of noradrenaline. Exp Brain Res 45: 317-327.
45. Kawaguchi Y, Shindou T. 1998. Noradrenergic excitation and inhibition of GABAergic cell types in rat frontal cortex. J Neurosci 18: 6963-6976.
46. Kelly PH, Seviour PW, Iversen SD. 1975. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94: 507-522.
47. Kokkinidis L, Anisman H. 1978. Involvement of norepinephrine in startle arousal after acute and chronic d-amphetamine administration. Psychopharmacology (Berl) 59: 285-292.
48. Koob GF, Bloom FE. 1988. Cellular and molecular mechanisms of drug dependence. Science 242: 715-723.
49. Kroner S, Krimer LS, Lewis DA, Barrionuevo G. 2007. Dopamine increases inhibition in the monkey dorsolateral prefrontal cortex through cell type-specific modulation of interneurons. Cereb Cortex 17: 1020-1032.
50. Kuczenski R, Segal DS. 1994. Neurochemistry of amphetamine. In: Cho AK, Segal DS, editors. Amphetamine and its analogues: psychopharmacology, toxicology, and abuse. San Diego: Academic Press. p 81-113.
51. Kuczenski R, Segal DS. 2001. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J Pharmacol Exp Ther 296: 876-883.
52. Kuczenski R, Segal DS. 2002. Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 22: 7264-7271.
53. Kuczenski R, Segal DS, Cho AK, Melega W. 1995. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J Neurosci 15: 1308-1317.
54. Lapiz MD, Morilak DA. 2006. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 137: 1039-1049.
55. Law-Tho D, Hirsch JC, Crepel F. 1994. Dopamine modulation of synaptic transmission in rat prefrontal cortex: an in vitro electrophysiological study. Neurosci Res 21: 151-160.
56. Li BM, Mao ZM, Wang M, Mei ZT. 1999. Alpha-2 adrenergic modulation of prefrontal cortical neuronal activity related to spatial working memory in monkeys. Neuropsychopharmacology 21: 601-610.
57. Manunta Y, Edeline JM. 1997. Effects of noradrenaline on frequency tuning of rat auditory cortex neurons. Eur J Neurosci 9: 833-847.
58. Mavridis M, Colpaert FC, Millan MJ. 1991. Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by alpha 1 as compared to alpha 2 agonists and antagonists. Brain Res 562: 216-224.
59. McCormick DA. 1989. Cholinergic and noradrenergic modulation of thalamocortical processing. Trends Neurosci 12: 215-221.
60. McCormick DA, Prince DA. 1988. Noradrenergic modulation of firing pattern in guinea pig and cat thalamic neurons, in vitro. J Neurophysiol 59: 978-996.
61. McGaughy J, Sarter M. 1995. Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology (Berl) 117: 340-357.
62. McLean J, Waterhouse BD. 1994. Noradrenergic modulation of cat area 17 neuronal responses to moving visual stimuli. Brain Res 667: 83-97.
63. Mehta MA, Sahakian BJ, Robbins TW. 2001. Comparative psychopharmacology of methylphenidate and related drugs in human volunteers, patients with ADHD, and experimental animals. In: Solanto MV, Arnsten AFT, Castellanos FX, editors. Stimulant drugs and ADHD: basic and clinical neuroscience. New York: Oxford University Press. p 301-331.
64. Miner LH, Jedema HP, Moore FW, Blakely RD, Grace AA, Sesack SR. 2006. Chronic stress increases the plasmalemmal distribution of the norepinephrine transporter and the coexpression of tyrosine hydroxylase in norepinephrine axons in the prefrontal cortex. J Neurosci 26: 1571-1578.
65. Mingote S, de Bruin JP, Feenstra MG. 2004. Noradrenaline and dopamine efflux in the prefrontal cortex in relation to appetitive classical conditioning. J Neurosci 24: 2475-2480.
66. Mooney RD, Bennett-Clarke C, Chiaia NL, Sahibzada N, Rhoades RW. 1990. Organization and actions of the noradrenergic input to the hamster's superior colliculus. J Comp Neurol 292: 214-230.
67. Moore K. 1978. Amphetamines: biochemical and behavioral actions in animals. In: Iversen LL, Iversen SD, Snyder SH, editors. Handbook of psychopharmacology. New York: Plenum. p 41-98.
68. Morilak DA, Barrera G, Echevarria DJ, Garcia AS, Hernandez A, Ma S, Petre CO. 2005. Role of brain norepinephrine in the behavioral response to stress. Prog Neuro Psychopharmacology Biol Psychiatry 29: 1214-1224.
69. Mountcastle VB, Andersen RA, Motter BC. 1981. The influence of attentive fixation upon the excitability of the light-sensitive neurons of the posterior parietal cortex. J Neurosci 1: 1218-1225.
70. Murphy BL, Arnsten AF, Jentsch JD, Roth RH. 1996. Dopamine and spatial working memory in rats and monkeys: pharmacological reversal of stress-induced impairment. J Neurosci 16: 7768-7775.
71. Nissanov J, Eaton RC. 1989. Reticulospinal control of rapid escape turning maneuvers in fishes. Am Zool 29: 103-121.
72. Nissanov J, Eaton RC, DiDomenico R. 1990. The motor output of the Mauthner cell, a reticulospinal command neuron. Brain Res 517: 88-98.
73. Ogren SO, Archer T, Johansson C. 1983. Evidence for a selective brain noradrenergic involvement in the locomotor stimulant effects of amphetamine in the rat. Neurosci Lett 43: 327-331.
74. Onn SP, Wang XB, Lin M, Grace AA. 2006. Dopamine D1 and D4 receptor subtypes differentially modulate recurrent excitatory synapses in prefrontal cortical pyramidal neurons. Neuropsychopharmacology 31: 318-338.
75. Parasuraman R, Warm JS, Dember WN. 1987. Vigilance: taxotomy and utility. In: Mark LS, Warm JS, Huston RL, editors. Ergonomics and human factors. New York: Springer. p 11-32.
76. Pascucci T, Ventura R, Latagliata EC, Cabib S, Puglisi-Allegra S. 2007. The medial prefrontal cortex determines the accumbens dopamine response to stress through the opposing influences of norepinephrine and dopamine. Cereb Cortex 17: 2796-2804.
77. Paspalas CD, Goldman-Rakic PS. 2005. Presynaptic d1 dopamine receptors in primate prefrontal cortex: target-specific expression in the glutamatergic synapse. J Neurosci 25: 1260-1267.
78. Penit-Soria J, Audinat E, Crepel F. 1987. Excitation of rat prefrontal cortical neurons by dopamine: an in vitro electrophysiological study. Brain Res 425: 263-274.
79. Pfingst BE, O'Connor TA, Miller JM. 1977. Response plasticity of neurons in auditory cortex of the rhesus monkey. Exp Brain Res 29: 393-404.
80. Pliszka SR. 2001. Comparing the effects of stimulant and non-stimulant agents on catecholamine function: implications for theories of ADHD. In: Solanto MV, Arnsten AFT, Castellanos FX, editors. Psychostimulant drugs and ADHD: basic and clinical neuroscience. New York: Oxford University Press. p 332-354.
81. Randrup A, Munkvad I. 1966. Role of catecholamines in the amphetamine excitatory response. Nature 211: 540.
82. Rapoport JL, Buchsbaum MS, Weingartner H, Zahn TP, Ludlow C, Mikkelsen EJ. 1980. Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men. Arch Gen Psychiatry 37: 933-943.
83. Rebec GV, Bashore TR. 1984. Critical issues in assessing the behavioral effects of amphetamine. Neurosci Biobehav Rev 8: 153-159.
84. Repantis D, Schlattmann P, Laisney O, Heuser I. 2010. Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res 62: 187-206.
85. Rogawski MA, Aghajanian GK. 1980a. Activation of lateral geniculate neurons by norepinephrine: mediation by an alpha-adrenergic receptor. Brain Res 182: 345-359.
86. Rogawski MA, Aghajanian GK. 1980b. Norepinephrine and serotonin: opposite effects on the activity of lateral geniculate neurons evoked by optic pathway stimulation. Exp Neurol 69: 678-694.
87. Rossetti ZL, Carboni S. 2005. Noradrenaline and dopamine elevations in the rat prefrontal cortex in spatial working memory. J Neurosci 25: 2322-2329.
88. Sato H, Kayama Y. 1983. Effects of noradrenaline applied iontophoretically on rat superior collicular neurons. Brain Res Bull 10: 453-457.
89. Sawaguchi T, Goldman-Rakic PS. 1994. The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J Neurophysiol 71: 515-528.
90. Sawaguchi T, Matsumura M, Kubota K. 1988. Dopamine enhances the neuronal activity of spatial short-term memory task in the primate prefrontal cortex. Neurosci Res 5: 465-473.
91. Sawaguchi T, Matsumura M, Kubota K. 1990. Catecholaminergic effects on neuronal activity related to a delayed response task in monkey prefrontal cortex. J Neurophysiol 63: 1385-1400.
92. Seamans JK, Durstewitz D, Christie BR, Stevens CF, Sejnowski TJ. 2001a. Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. Proc Natl Acad Sci USA 98: 301-306.
93. Seamans JK, Gorelova N, Durstewitz D, Yang CR. 2001b. Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci 21: 3628-3638.
94. Segal DS. 1975. Behavioral and neurochemical correlates of repeated d-amphetamine administration. Adv Biochem Psychopharmacol 13: 247-262.
95. Sessler FM, Liu W, Kirifides ML, Mouradian RD, Lin RC, Waterhouse BD. 1995. Noradrenergic enhancement of GABA-induced input resistance changes in layer V regular spiking pyramidal neurons of rat somatosensory cortex. Brain Res 675: 171-182.
96. Sessler FM, Mouradian RD, Cheng JT, Yeh HH, Liu WM, Waterhouse BD. 1989. Noradrenergic potentiation of cerebellar Purkinje cell responses to GABA: evidence for mediation through the beta-adrenoceptor-coupled cyclic AMP system. Brain Res 499: 27-38.
97. Sessler FM, Wang H, Waterhouse BD, Gao WJ. 2008. Opposing effects of dopamine and norepinephrine in modulation of prefrontal microcircuit between pyramidal neurons and fast-spiking interneurons. Program No. 161.16. 2008 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience.
98. Shumsky JS, Baynard MD, Nissanov J. 2000. Dissociation of vigilance states during performance in a sustained attention procedure. Program No. 837.4. 2000 Neuroscience Meeting Planner. New Orleans, LA: Society for Neuroscience.
99. Shumsky JS, Beck AW, Dyutin D, Clark BD, Waterhouse BD. 2009. Oral methylphenidate enhancement of performance in a sustained attention task is blocked by prazosin. Program No. 873.13. 2009 Neuroscience Meeting Planner. Chicago, IL: Society for Neuroscience.
100. Shumsky JS, Danley JE, Bertrand L, Drouin C, Nissanov J, Waterhouse BD. 2004. Low dose methylphenidate improves vigilance performance in a sustained attention task. Program No. 800.4. 2004 Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience.
101. Smith GS, Danley JE, Waterhouse BD, Shumsky JS. 2005. Chronic low dose methylphenidate treatment improves both vigilance and the acquisition of a sustained attention task. Program No. 664.15. 2005 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience.
102. Snow PJ, Andre P, Pompeiano O. 1999. Effects of locus coeruleus stimulation on the responses of SI neurons of the rat to controlled natural and electrical stimulation of the skin. Arch Ital Biol 137: 1-28.
103. Solanto MV. 1998. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94: 127-152.
104. Solanto MV. 2001. Attention-deficit/hyperactivity disorder. In: Solanto MV, Arnsten AFT, Castellanos FX, editors. Stimulant drugs and ADHD: basic and clinical neuroscience. New York: Oxford University Press. p 3-30.
105. Stephens DN, Sarter M. 1988. Bidirectional nature of benzodiazepine receptor ligands extends to effects on vigilance. In: Hindmarch I, Ott H, editors. Benzodiazepine receptor ligands, memory and information processing. Berlin: Springer. p 205-217.
106. Steriade M, Iosif G, Apostol V. 1969. Responsiveness of thalamic and cortical motor relays during arousal and various stages of sleep. J Neurophysiol 32: 251-265.
107. Steriade M, McCarley RW. 1990. Brainstem control of wakefulness and sleep. New York: Plenum.
108. Swanson J, Volkow N. 2001. Pharmacokinetic and pharmacodynamic properties of methylphenidate in humans. In: Solanto MV, Arnsten AFT, Castellanos FX, editors. Psychostimulant drugs and ADHD: basic and clinical neuroscience. New York: Oxford University Press. p 259-282.
109. Tanila H, Rama P, Carlson S. 1996. The effects of prefrontal intracortical microinjections of an alpha-2 agonist, alpha-2 antagonist and lidocaine on the delayed alternation performance of aged rats. Brain Res Bull 40: 117-119.
110. Trantham-Davidson H, Neely LC, Lavin A, Seamans JK. 2004. Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex. J Neurosci 24: 10652-10659.
111. Urban NN, Gonzalez-Burgos G, Henze DA, Lewis DA, Barrionuevo G. 2002. Selective reduction by dopamine of excitatory synaptic inputs to pyramidal neurons in primate prefrontal cortex. J Physiol 539: 707-712.
112. Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH, Gabrieli JD. 1998. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci USA 95: 14494-14499.
113. Ventura R, Alcaro A, Puglisi-Allegra S. 2005. Prefrontal cortical norepinephrine release is critical for morphine-induced reward, reinstatement and dopamine release in the nucleus accumbens. Cereb Cortex 15: 1877-1886.
114. Ventura R, Cabib S, Alcaro A, Orsini C, Puglisi-Allegra S. 2003. Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release. J Neurosci 23: 1879-1885.
115. Ventura R, Morrone C, Puglisi-Allegra S. 2007. Prefrontal/accumbal catecholamine system determines motivational salience attribution to both reward- and aversion-related stimuli. Proc Natl Acad Sci USA 104: 5181-5186.
116. Videen TO, Daw NW, Rader RK. 1984. The effect of norepinephrine on visual cortical neurons in kittens and adult cats. J Neurosci 4: 1607-1617.
117. Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AFT. 2007. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci 10: 376-384.
118. Wang H, Stradtman GG, Wang XJ, Gao WJ. 2008. A specialized NMDA receptor function in layer 5 recurrent microcircuitry of the adult rat prefrontal cortex. Proc Natl Acad Sci USA 105: 16791-16796.
119. Wang HX, Gao WJ. 2009. Cell type-specific development of NMDA receptors in the interneurons of rat prefrontal cortex. Neuropsychopharmacology 34: 2028-2040.
120. Wang HX, Gao WJ. 2010. Development of calcium-permeable AMPA receptors and their correlation with NMDA receptors in fast-spiking interneurons of rat prefrontal cortex. J Physiol 588: 2823-2838.
121. Wang M, Ramos BP, Paspalas CD, Shu Y, Simen A, Duque A, Vijayraghavan S, Brennan A, Dudley A, Nou E, Mazer JA, McCormick DA, Arnsten AFT. 2007. Alpha-2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell 129: 397-410.
122. Wang X, Zhong P, Yan Z. 2002. Dopamine D4 receptors modulate GABAergic signaling in pyramidal neurons of prefrontal cortex. J Neurosci 22: 9185-9193.
123. Wargin W, Patrick K, Kilts C, Gualtieri CT, Ellington K, Mueller RA, Kraemer G, Breese GR. 1983. Pharmacokinetics of methylphenidate in man, rat and monkey. J Pharmacol Exp Ther 226: 382-386.
124. Waterhouse BD, Azizi SA, Burne RA, Woodward DJ. 1990. Modulation of rat cortical area 17 neuronal responses to moving visual stimuli during norepinephrine and serotonin microiontophoresis. Brain Res 514: 276-292.
125. Waterhouse BD, Moises HC, Woodward DJ. 1980. Noradrenergic modulation of somatosensory cortical neuronal responses to iontophoretically applied putative neurotransmitters. Exp Neurol 69: 30-49.
126. Waterhouse BD, Moises HC, Woodward DJ. 1981. Alpha-receptor-mediated facilitation of somatosensory cortical neuronal responses to excitatory synaptic inputs and iontophoretically applied acetylcholine. Neuropharmacology 20: 907-920.
127. Waterhouse BD, Moises HC, Woodward DJ. 1998. Phasic activation of the locus coeruleus enhances responses of primary sensory cortical neurons to peripheral receptive field stimulation. Brain Res 790: 33-44.
128. Waterhouse BD, Moises HC, Yeh HH, Woodward DJ. 1982. Norepinephrine enhancement of inhibitory synaptic mechanisms in cerebellum and cerebral cortex: mediation by beta adrenergic receptors. J Pharmacol Exp Ther 221: 495-506.
129. Waterhouse BD, Mouradian R, Sessler FM, Lin RC. 2000. Differential modulatory effects of norepinephrine on synaptically driven responses of layer V barrel field cortical neurons. Brain Res 868: 39-47.
130. Waterhouse BD, Sessler FM, Cheng JT, Woodward DJ, Azizi SA, Moises HC. 1988. New evidence for a gating action of norepinephrine in central neuronal circuits of mammalian brain. Brain Res Bull 21: 425-432.
131. Waterhouse BD, Woodward DJ. 1980. Interaction of norepinephrine with cerebrocortical activity evoked by stimulation of somatosensory afferent pathways in the rat. Exp Neurol 67: 11-34.
132. Williams GV, Castner SA. 2006. Under the curve: critical issues for elucidating D1 receptor function in working memory. Neuroscience 139: 263-276.
133. Williams GV, Goldman-Rakic PS. 1995. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376: 572-575.
134. Wise RA. 1987. The role of reward pathways in the development of drug dependence. Pharmacol Ther 35: 227-263.
135. Woodward DJ, Moises HC, Waterhouse BD, Hoffer BJ, Freedman R. 1979. Modulatory actions of norepinephrine in the central nervous system. Fed Proc 38: 2109-2116.
136. Zahrt J, Taylor JR, Mathew RG, Arnsten AF. 1997. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17: 8528-8535.
137. Zhou FM, Hablitz JJ. 1999. Dopamine modulation of membrane and synaptic properties of interneurons in rat cerebral cortex. J Neurophysiol 81: 967-976.